Cristina Hurlbut, MD
Family Medicine · Wenatchee, WANPI 1134484298
Payments from drug & device makers
Across 48 payments — averaging $16.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$142
- Amgen$131
- Novo Nordisk$102
- Astellas Pharma US Inc$84
- Sanofi-aventis U.S. LLC$52
- E.r. Squibb & Sons, L.L.C.$46
- plus $222 from 11 others
What the payments were for
- Food & beverage$779100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 7 | $142 |
| Amgen | 10 | $131 |
| Novo Nordisk | 6 | $102 |
| Astellas Pharma US Inc | 5 | $84 |
| Sanofi-aventis U.S. LLC | 3 | $52 |
| E.r. Squibb & Sons, L.L.C. | 3 | $46 |
| Bayer | 2 | $28 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $28 |
| Kowa Pharmaceuticals America, Inc. | 2 | $24 |
| Boston Scientific | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Ceribell, Inc. | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Biogen | 1 | $16 |
| GSK | 1 | $12 |
How this compares
$779 in reported general payments places this provider in the 80th percentile of 2,275 family medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $6,011 |
| Atorvastatin Calcium | 33 | $643 |
| Duloxetine Hcl | 24 | $494 |
| ClopidogrelClopidogrel Bisulfate | 20 | $283 |
| Lisinopril | 28 | $225 |
| Pantoprazole Sodium | 21 | $159 |
| Montelukast Sodium | 14 | $158 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 11 | $113 |
| Amlodipine Besylate | 14 | $94 |
| Levetiracetam | 11 | $52 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Wenatchee
- Anton GraschWenatchee$5.3M
- Steven KasterWenatchee$4M
- Kathryn ErenWenatchee$112K
- Andrew TothWenatchee$25K
- Gaylon KippBellevue$4.8M
- Angela EakinSpokane$3M
- Jonathan StabenCheney$2.5M
- Emily ZaragozaSeattle$1.9M
- Brad FrandsenPort Orchard$1.7M
- Kevin HatfieldSeattle$527K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.